Michigan Tech Researchers Receive MEDC Commercialization Funding
The Michigan Economic Development Corporation (MEDC) has funded five projects at Michigan Tech through the University's Michigan Translational Research and Commercialization (MTRAC) program. MTRAC supports the acceleration of commercially viable applied advanced material technologies developed by Michigan Tech researchers.
The projects funded are:
- Andrew Barnard (ME-EM)—Active Noise Control (ANC) with Carbon Nanotube Thin-films: a lightweight, small and immovable film used for “low noise” mode of operation for military ground and marine vehicles.
- Xiaohu Xia (Chem)—Artificial Enzymes: synthetic enzyme used in medical diagnostic kits to improve sensitivity and accuracy of test results.
- Jaroslaw Drelich (MSE) and Jeremy Goldman (Bio Med)—Bioabsorbable Stents: the bioabsorbable metal stents harmlessly erode within the desired timeframe and has demonstrated superiority to current materials.
- Bowen Li (MSE), —Microwave Vermiculite Exfoliation: an energy-efficient process for processing vermiculite and similar minerals.
- Feng Zhao (Bio Med),—Cell Patch for Wound Healing: composite tissue created from natural and artificial cells used to better heal wounds.
Read the full story.